Treatments

Feature

The ultimate face-saving feat

When half her face became paralyzed, a young nurse turned to a UMN surgeon.

Feature

Light at the end of a long, dark night

After decades of battling depression, a patient finds the right doctor at the U of M.

Mary Lou Peterson, gray hair and surgical mask, and Dr. Andy Grande, in white coat, mask and colorful cap, regard each other.

Feature

Leaving pain in the rear-view

After 10 years, a patient finds relief from debilitating facial pain in the hands of a skilled neurosurgeon.

Close up of a biocomputing chip made of bacteria.

Research Brief

The Trumpet biocomputing platform heralds a new path for medicine

University of Minnesota researchers have developed a new method of biocomputing with the potential to revolutionize medicine.

Research Brief

U of M research indicates clues to early detection and prevention of Alzheimer’s disease

College of Veterinary Medicine researchers Manci Li and Assistant Professor Peter Larsen looked at existing data from both Alzheimer’s brains and healthy brains to identify the key neuropeptides — the chemical messengers that are released by neurons — involved in Alzheimer’s. They also examined the relationship between neuropeptide activity and aging.

Image of someone’s pair of boots walking through the snow, one ankle slightly bent as if they are about to stumble.

Talking with U of M

Talking how to avoid winter injuries with the U of M

Dr. Mahmood Gharib talks about staying safe in the winter weather.

News Release

U of M begins Phase I of first-in-human clinical trial for advanced solid tumor cancers

Physicians and scientists at the University of Minnesota have opened a new solid tumor cancer clinical trial and have treated their first patient with HCW9218, an injectable, bifunctional immunotherapeutic, developed by HCW Biologics Inc (NASDAQ: HCWB).